Policy / Pricing RFK Jr. rewrites ACIP rules; Gilead, Roche dig into protein degraders BioPharma DiveThe newly published charter widens the required expertise to become an ACIP member and stresses vaccine safety.Policy / PricingRead full story pharminent April 10, 2026 (Last updated: April 10, 2026) BioPharma Dive The newly published charter widens the required expertise to become an ACIP member and stresses vaccine safety. Policy / PricingRead full story Post navigation Previous: With oral obesity race underway, all eyes are on Lilly’s Foundayo launchNext: Oricell closes a ‘pre-IPO’ megaround to aim CAR-T at solid tumors Related Stories Policy / Pricing UniQure, Replimune shares rise as FDA’s Makary exits, but path forward unchanged pharminent May 13, 2026 Policy / Pricing EU agrees plan to tackle essential medicine shortages pharminent May 12, 2026 Policy / Pricing 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar) pharminent May 12, 2026
